Role of the GM-CSF Pathway in Heterotopic Ossification Associated with Fibrodysplasia Ossificans Progressiva (FOP) and Novel Therapeutic Strategies to Suppress the Inflammatory Response

Awardee: Eileen M. Shore

Institution: University of Pennsylvania School of Medicine

Award Amount: $40,000

Funding Period: February 1, 2021 - January 31, 2022

Previous
Previous

Tissue inflammation in Mucopolysaccharidoses type II disease: molecular mechanism and therapy

Next
Next

Influence of microbiota on innate immune responses and heterotopic ossification in fibrodysplasia ossificans progressiva (FOP)